• Crohn's & Colitis Foundation funding microbiome IBD drug development

    3 monthes ago - By Healio

    New funding from the Crohn's & Colitis Foundation will help advance the development of a microbiome-derived therapy for the treatment of inflammatory bowel disease.
    Vedanta Biosciences said it hopes to build on the findings of one of its scientific co-founders, Kenya Honda, MD, PhD, of the Keio University School of Medicine, to develop a treatment to target bacteria that has been suggested as a potential trigger for IBD, according to a press release.
    “Dr. Honda's research suggests an entirely new approach to help IBD patients by specific elimination of pro-inflammatory bacteria”
    Read more ...